Patents-Review.com
ClassID:

113818 ⎘

C12Y104/03013 - CPC Classification

Classification description:

Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3) Protein-lysine 6-oxidase (1.4.3.13), i.e. lysyl-oxidase

Recent Application in this class:
#1
20260139105
2026-05-21

Collagen Hydrogel, Preparation Method Therefor, and Use Thereof

 #2
20250326217
2025-10-23

MINERAL WOOL PRODUCTS

 #3
20240398906
2024-12-05

PROPEPTIDE OF LYSYL OXIDASE FOR TREATMENT OF CANCER

 #4
20240375393
2024-11-14

MINERAL WOOL PRODUCT

 #5
20230166492
2023-06-01

Method of producing a mineral wool product comprising a multiple of lamellae and a product of such kind

 #6
20220049236
2022-02-17

COMPOSITIONS COMPRISING THE PROPEPTIDE OF LYSYL OXIDASE AND USES THEREOF

 #7
20210137988
2021-05-13

Ocular applications of matrix bound vesicles (MBVs)

 #8
20210106526
2021-04-15

MATRIX BOUND VESICLES (MBVS) CONTAINING IL-33 AND THEIR USE

 #9
20200345898
2020-11-05

EXTRACELLULAR MATRIX AND ITS USE FOR REGULATING THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS

 #10
20200317921
2020-10-08

Binder composition

 #11
20200308408
2020-10-01

BINDER COMPOSITION

 #12
20200308355
2020-10-01

Method of providing insulation to a structure

 #13
20200165399
2020-05-28

A FIRE-PROTECTING INSULATION PRODUCT AND USE OF SUCH PRODUCT

 #14
20200047478
2020-02-13

Method of bonding together surfaces of two or more elements and a product made by said method

 #15
20190390203
2019-12-26

REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS

 #16
20190211486
2019-07-11

MINERAL WOOL PRODUCTS

 #17
20190210323
2019-07-11

Method of producing a mineral wool product comprising a multiple of lamellae and a product of such kind

 #18
20190136427
2019-05-09

Mineral wool product

 #19
20190040470
2019-02-07

PHARMACEUTICAL COMPOSITIONS AND METHODS USEFUL FOR MODULATING ANGIOGENESIS, INHIBITING METASTASIS AND TUMOR FIBROSIS, AND ASSESSING THE MALIGNANCY OF COLON CANCER TUMORS

 #20
20180179545
2018-06-28

Reduction of lipase activity in product formulations

 #21
20160312226
2016-10-27

Reduction of lipase activity in product formulations

 #22
20160222128
2016-08-04

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

 #23
20160008421
2016-01-14

Method of altering vascular permeability and uses thereof

 #24
20150044199
2015-02-12

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

 #25
20130157361
2013-06-20

Catalytic domains from lysyl oxidase and LOXL2

 #26
20130022617
2013-01-24

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

 #27
20130011902
2013-01-10

Stimulation of the synthesis of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers

 #28
20120324593
2012-12-20

Lysyl oxidase-like 1 (LOXL1) and elastogenesis

 #29
20120202206
2012-08-09

PHARMACEUTICAL COMPOSITIONS AND METHODS USEFUL FOR MODULATING ANGIOGENESIS, INHIBITING METASTASIS AND TUMOR FIBROSIS, AND ASSESSING THE MALIGNANCY OF COLON CANCER TUMORS

 #30
20120165398
2012-06-28

Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors

 #31
20110076739
2011-03-31

Catalytic domains from lysyl oxidase and LOXL2

 #32
20110014175
2011-01-20

STIMULATION OF THE SYNTHESIS OF THE ACTIVITY OF AN ISOFORM OF LYSL OXIDASE-LIKE LOXL FOR STIMULATING THE FORMATION OF ELASTIC FIBRES

 #33
20100317721
2010-12-16

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

 #34
20100203029
2010-08-12

Lysyl oxidase-like 1 (LOXL1) and elastogenesis

 #35
20100119515
2010-05-13

Methods and compositions for modulating angiogenesis

 #36
20100040710
2010-02-18

Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers.

 #37
20090022703
2009-01-22

Lysyl oxidase-like 1 (LOXL1) and elastogenesis

 #38
20080261870
2008-10-23

Use of the Pro-Peptide Domain of Lysyl Oxidase as a Therapeutic Agent

 #39
20080064021
2008-03-13

Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity

 #40
20080038243
2008-02-14

WOUND HEALING COMPOSITIONS AND METHODS USING TROPOELASTIN AND LYSYL OXIDASE

 #41
20070225242
2007-09-27

Method and composition for treating and preventing tumor metastasis in vivo

 #42
20070202143
2007-08-30

Direct application of non-toxic crosslinking reagents to restabilize surgically destabilized intervertebral joints

 #43
20070021365
2007-01-25

Inhibition of Lysyl oxidase for treating tumor growth and diagnostics relating thereto

 #44
20060127402
2006-06-15

Method for assessing metastatic properties of breast cancer

 #45
20060029588
2006-02-09

Lysyl oxidase-like 1 (LOXL1) and elastogenesis

 #46
20050188427
2005-08-25

Lysyl oxidase-like 1 (LOXL1) and elastogenesis

 #47
20050175600
2005-08-11

Wound healing compositions and methods using tropoelastin and lysyl oxidase